Form 4: Quest Diagnostics Director Timothy M. Ring Reports Changes in Beneficial Ownership

Director Timothy M. Ring reports acquisition of phantom stock units and adjustments to holdings due to dividend reinvestment in Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors.

Summary

• Timothy M. Ring, a director of Quest Diagnostics, filed a Form 4 indicating changes in beneficial ownership.
• The reported transaction date is January 2, 2025.
• Ring acquired 281 phantom stock units due to elective deferrals of cash compensation under the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors.
• These phantom stock units become payable in cash upon termination of service as a director.
• The filing also reflects an adjustment to the amount of securities beneficially owned following reported transactions, including shares acquired via dividend reinvestment since the last Form 4 filing.
• Following the reported transactions, Ring directly owns 16,081.414 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects routine transactions and participation in compensation plans, indicating alignment with the company's long-term interests. There are no explicitly negative indicators.

Positives

• The acquisition of phantom stock units reflects Ring's continued participation in the company's deferred compensation plan.
• Dividend reinvestment indicates a long-term investment strategy and confidence in the company's performance.

Future Outlook

The document does not contain specific forward-looking statements, but the director's participation in the deferred compensation plan and dividend reinvestment suggest a continued alignment with the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the holdings of a director at Quest Diagnostics, a major player in the diagnostic testing industry.

Comparison to Industry Standards

• Executive compensation structures, including deferred compensation plans and stock ownership, are common across publicly traded companies.
• Dividend reinvestment programs are also standard practice, allowing shareholders to increase their holdings over time.
• Comparing Ring's stock ownership and compensation structure to those of directors at comparable companies like Laboratory Corporation of America (LH) or Bio-Reference Laboratories can provide further context.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the transactions of a company director.
• The director's participation in compensation plans and dividend reinvestment aligns their interests with those of shareholders.

Key Dates